| 25.58 Data as of 4:03pm ET |  +0.10 / +0.39%Today’s Change | 17.13 Today|||52-Week Range 29.57 | +38.27% Year-to-Date |
| This Metric Says You're Smart to Own Alere Jun 07 / MotleyFool.com | Malaria push hones techniques fit for a US president May 30 / FT.com |
| Previous close | 25.48 |
| Today’s open | 25.49 |
| Day’s range | 25.44 - 25.74 |
| Volume | 146,123 |
| Average volume (3 months) | 632,781 |
| Market cap | $2.1B |
| Dividend yield | -- |
| Earnings growth (last year) | +22.15% |
| Earnings growth (this year) | -3.11% |
| Earnings growth (next 5 years) | +12.50% |
| Revenue growth (last year) | +18.11% |
| P/E ratio | NM |
| Price/Sales | 0.53 |
| Price/Book | 1.31 |
| Today’s change | Today’s % change | |
|---|---|---|
| TECHTechne Corp | +1.09 | +1.62% |
| NEOGNeogen Corp | +0.30 | +0.55% |
| GHDXGenomic Health Inc | +1.08 | +3.28% |
| VIVOMeridian Bioscience ... | +0.22 | +1.02% |
| Next reporting date | July 31, 2013 |
| EPS forecast (this quarter) | $0.48 |
| Annual revenue (last year) | $2.8B |
| Annual profit (last year) | -$78.2M |
| Net profit margin | -2.77% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chairman, President & Chief Executive Officer Ronald Zwanziger, MBA |
Chief Operating Officer Namal Nawana, MBA |
Corporate headquarters Waltham, Massachusetts |
.
